Avance Biosciences, Inc.

Equipped with leading platforms, including Illumina, PacBio, Oxford Nanopore, Element AVITI™, 10x Genomics, and Mission Bio Tapestri™, we offer unmatched expertise in vector characterization, transgene expression, CRISPR analysis, biodistribution, and release testing.

Reliable bioanalytical assays are critical to advancing biologics, vaccines, and cell and gene therapies. Avance Biosciences delivers GLP-compliant assay development and validation to ensure accuracy, regulatory confidence, and streamlined drug development.

The colony-forming unit (CFU) assay is considered the gold standard in vitro functional assay for identifying and enumerating hematopoietic progenitor cells. Avance has integrated the STEMvision™ Platform into our suite of analytical tools to enhance our capability to support gene and cell therapy product characterization for regulatory submissions.

ELISA’s versatility makes it indispensable in research, diagnostics, and drug development, providing essential data for understanding disease mechanisms, monitoring treatment efficacy, and advancing therapeutic innovations. Avance Biosciences provides comprehensive CGMP/GLP-compliant ELISA lab services that are tailored to meet the diverse needs of your projects, from early-stage research to clinical trials and quality control.

Understanding where your viral vector integrates into the host genome is critical for safety, efficacy, and regulatory success. At Avance Biosciences, our advanced NGS-based integration site analysis, including validated methods like Target Enrichment Sequencing, LAM-PCR, and Whole Genome Sequencing, offers high-resolution mapping to support vector optimization and therapeutic development. From CHO cell line characterization to CAR-T therapies and plasmid vaccines, we deliver the insights needed to move your programs forward with confidence.

At Avance Biosciences, our state-of-the-art LC-MS platforms, featuring the SCIEX QTRAP 6500+ and TripleTOF 6600, deliver the sensitivity, specificity, and accuracy required for today’s complex pharmaceutical and biopharmaceutical challenges. From small molecule PK/PD studies to targeted proteomics, metabolite profiling, and biologics characterization, our expert team supports you with high-throughput, GMP-compliant solutions tailored to your program's needs.